glp-1 amgen Redefining Obesity Care: The Revolution GIPR antagonist antibodies conjugated to
Description
A recent umbrella review encompassing data from 108,030 men with diabetes estimated a global pooled prevalence of 65.8% [10]
DM: diabetes mellitus
This includes both true off-label utilization, as well as improper engagement with physicians and care coordination
doi: 10.1016/s0006-291x(05)80836-8
